Single-cell epigenome-wide association study (scEWAS)
Single-Cell Epigenome-Wide Association Study · Also known as: scEWAS, single-cell EWAS, sc-epigenome association study, single-cell chromatin accessibility EWAS
A single-cell epigenome-wide association study (scEWAS) interrogates epigenetic marks — primarily DNA methylation or chromatin accessibility — across the entire genome at single-cell resolution, then statistically associates variation in those marks with a phenotype, disease, or exposure. By resolving cell-type heterogeneity that bulk EWAS cannot separate, scEWAS identifies epigenetic signals that are specific to rare or intermixed cell populations rather than averaged across tissues.
Read the full method
Sign in with a free account to read this section.
Method map
The neighbourhood of related methods — select a node to explore.
When to use it
Use scEWAS when your research question requires cell-type-resolved epigenetic associations — for instance, linking chromatin accessibility differences to a disease trait within specific immune subpopulations, neuronal subtypes, or rare progenitor cells. It is the method of choice when bulk EWAS has produced inconsistent or null results suspected to arise from cell-type heterogeneity, or when cell-type composition itself is a potential confounder. Avoid scEWAS when sample sizes are small (fewer than ~20 donors with matched single-cell data and phenotype), when the epigenome-wide question does not require cell-type resolution, or when cost and data complexity are prohibitive — in those cases, bulk EWAS with cell-type deconvolution is a more practical alternative. The method also requires substantial computational infrastructure and careful quality-control expertise.
Strengths & limitations
- Resolves cell-type-specific epigenetic associations that are completely masked in bulk tissue data.
- Simultaneously characterises cell-type composition and epigenetic variation, enabling compositional confounding to be modelled explicitly.
- Compatible with multi-omics integration — single-cell ATAC-seq data can be co-analysed with scRNA-seq from the same cells (SHARE-seq, 10x Multiome).
- Enables discovery of disease-relevant epigenetic signals in rare cell populations that comprise a small fraction of the tissue.
- Continuously evolving toolkit (ArchR, Signac, scOpen) provides robust, well-documented computational infrastructure.
- Requires large sample sizes of donors (not just cells) to achieve adequate statistical power for association testing; many existing datasets are underpowered for scEWAS.
- Single-cell epigenomic data are sparse — each cell covers only a fraction of the genome — making locus-level inference noisy without aggregation strategies.
- High sequencing costs and complex wet-lab protocols limit accessibility compared to bulk EWAS arrays.
- Pseudo-bulk aggregation collapses within-cell-type heterogeneity and reintroduces some of the same averaging problems as bulk approaches.
- Cell-type annotation errors propagate into association results; mis-clustering can produce spurious or missed associations.
Frequently asked
How is scEWAS different from bulk EWAS?
Bulk EWAS measures the average epigenetic signal across all cells in a tissue sample and tests that average against a phenotype. scEWAS resolves individual cells, clusters them by cell type, and tests epigenetic–trait associations within specific populations. This eliminates cell-type composition as a confounder and can reveal signals restricted to minority cell types that bulk EWAS would dilute below detection.
How many donors are needed for a scEWAS?
Power calculations depend on effect size and cell-type frequency, but as a rough guide, at least 20–50 donors with matched single-cell epigenomic data and phenotype annotations are needed for adequately powered association testing. Rare cell types require larger samples because fewer cells per donor can be aggregated for pseudo-bulk analysis. Studies with fewer than 20 donors should be treated as discovery-only and require replication.
Should I use pseudo-bulk aggregation or test at the single-cell level?
For donor-level phenotype associations (disease status, continuous trait), pseudo-bulk aggregation — summing or averaging signal within each cell type per donor — is strongly recommended. Single-cell-level tests inflate the sample size by treating cells as independent, leading to severely anti-conservative p-values. Pseudo-bulk approaches followed by standard donor-level regression or mixed models are statistically appropriate and best-practice.
What platforms generate the input data for scEWAS?
The most common platform is single-cell ATAC-seq (e.g., 10x Genomics Chromium, SHARE-seq), which profiles chromatin accessibility genome-wide per cell. For DNA methylation at single-cell resolution, single-cell bisulfite sequencing (scBS-seq) or snmC-seq are used, though their coverage is sparser. CUT&TAG adapted to single cells can target specific histone marks. Each platform has different coverage depth, cost, and throughput trade-offs.
Can scEWAS findings be integrated with GWAS results?
Yes — this is one of the most powerful applications. Significant scEWAS loci (especially open chromatin regions) can be intersected with GWAS risk variants to identify the cell types in which genetic variants likely exert their regulatory effects. Tools such as LDSC applied to cell-type-specific peaks, or colocalization methods (coloc), formally test whether GWAS signals and cell-type epigenetic signals share the same underlying variant.
Sources
- Zhang, Y., et al. (2022). Single-cell epigenome analysis reveals age-associated decay of heterochromatin domains in excitatory neurons in the mouse brain. Cell Research, 32(1), 1-18. link ↗
- Aryee, M. J., et al. (2014). Minfi: a flexible and comprehensive Bioconductor package for the analysis of Infinium DNA methylation microarrays. Bioinformatics, 30(10), 1363-1369. DOI: 10.1093/bioinformatics/btu049 ↗
How to cite this page
ScholarGate. (2026, June 3). Single-Cell Epigenome-Wide Association Study. ScholarGate. https://scholargate.app/en/bioinformatics/single-cell-epigenome-wide-association-study
Which method?
Set this method beside its closest kin and read them side by side — the library lays the books on the table; the choice is yours.
- Epigenome-wide association studyBioinformatics↔ compare